Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan
Identifieur interne : 001299 ( Istex/Corpus ); précédent : 001298; suivant : 001300Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan
Auteurs : Masataka Nishimura ; Ryuji Kaji ; Mitsuhiro Ohta ; Ikuko Mizuta ; Sadako KunoSource :
- Movement Disorders [ 0885-3185 ] ; 2002-07.
English descriptors
- KwdEn :
Abstract
We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10187
Links to Exploration step
ISTEX:B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
<author><name sortKey="Nishimura, Masataka" sort="Nishimura, Masataka" uniqKey="Nishimura M" first="Masataka" last="Nishimura">Masataka Nishimura</name>
<affiliation><mods:affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name>
<affiliation><mods:affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ohta, Mitsuhiro" sort="Ohta, Mitsuhiro" uniqKey="Ohta M" first="Mitsuhiro" last="Ohta">Mitsuhiro Ohta</name>
<affiliation><mods:affiliation>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mizuta, Ikuko" sort="Mizuta, Ikuko" uniqKey="Mizuta I" first="Ikuko" last="Mizuta">Ikuko Mizuta</name>
<affiliation><mods:affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name>
<affiliation><mods:affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10187</idno>
<idno type="url">https://api.istex.fr/document/B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001299</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
<author><name sortKey="Nishimura, Masataka" sort="Nishimura, Masataka" uniqKey="Nishimura M" first="Masataka" last="Nishimura">Masataka Nishimura</name>
<affiliation><mods:affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name>
<affiliation><mods:affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ohta, Mitsuhiro" sort="Ohta, Mitsuhiro" uniqKey="Ohta M" first="Mitsuhiro" last="Ohta">Mitsuhiro Ohta</name>
<affiliation><mods:affiliation>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mizuta, Ikuko" sort="Mizuta, Ikuko" uniqKey="Mizuta I" first="Ikuko" last="Mizuta">Ikuko Mizuta</name>
<affiliation><mods:affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name>
<affiliation><mods:affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-07">2002-07</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="831">831</biblScope>
<biblScope unit="page" to="832">832</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69</idno>
<idno type="DOI">10.1002/mds.10187</idno>
<idno type="ArticleID">MDS10187</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term>
<term>case‐control study</term>
<term>dopamine transporter</term>
<term>early‐onset Parkinson's disease</term>
<term>polymorphism</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Masataka Nishimura MD</name>
<affiliations><json:string>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</json:string>
</affiliations>
</json:item>
<json:item><name>Ryuji Kaji MD</name>
<affiliations><json:string>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</json:string>
</affiliations>
</json:item>
<json:item><name>Mitsuhiro Ohta PhD</name>
<affiliations><json:string>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</json:string>
</affiliations>
</json:item>
<json:item><name>Ikuko Mizuta PhD</name>
<affiliations><json:string>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</json:string>
</affiliations>
</json:item>
<json:item><name>Sadako Kuno MD</name>
<affiliations><json:string>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>dopamine transporter</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>polymorphism</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>case‐control study</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>early‐onset Parkinson's disease</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society</abstract>
<qualityIndicators><score>6.172</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>612 x 792 pts (letter)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>5</keywordCount>
<abstractCharCount>369</abstractCharCount>
<pdfWordCount>10043</pdfWordCount>
<pdfCharCount>66444</pdfCharCount>
<pdfPageCount>15</pdfPageCount>
<abstractWordCount>56</abstractWordCount>
</qualityIndicators>
<title>Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
<genre><json:string>brief communication</json:string>
</genre>
<host><volume>17</volume>
<pages><total>2</total>
<last>832</last>
<first>831</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>4</issue>
<subject><json:item><value>Clinical/Scientific Note</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<eissn><json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi><json:string>10.1002/mds.10187</json:string>
</doi>
<id>B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<availability><p>WILEY</p>
</availability>
<date>2002</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
<author><persName><forename type="first">Masataka</forename>
<surname>Nishimura</surname>
</persName>
<roleName type="degree">MD</roleName>
<note type="correspondence"><p>Correspondence: Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima 770‐8503, Japan</p>
</note>
<affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</affiliation>
</author>
<author><persName><forename type="first">Ryuji</forename>
<surname>Kaji</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</affiliation>
</author>
<author><persName><forename type="first">Mitsuhiro</forename>
<surname>Ohta</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</affiliation>
</author>
<author><persName><forename type="first">Ikuko</forename>
<surname>Mizuta</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</affiliation>
</author>
<author><persName><forename type="first">Sadako</forename>
<surname>Kuno</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-07"></date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="831">831</biblScope>
<biblScope unit="page" to="832">832</biblScope>
</imprint>
</monogr>
<idno type="istex">B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69</idno>
<idno type="DOI">10.1002/mds.10187</idno>
<idno type="ArticleID">MDS10187</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2002</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head>
<item><term>Parkinson's disease</term>
</item>
<item><term>dopamine transporter</term>
</item>
<item><term>polymorphism</term>
</item>
<item><term>case‐control study</term>
</item>
<item><term>early‐onset Parkinson's disease</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>article category</head>
<item><term>Clinical/Scientific Note</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2001-07-12">Received</change>
<change when="2002-01-11">Registration</change>
<change when="2002-07">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>New York</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/mds.v17:4</doi>
<numberingGroup><numbering type="journalVolume" number="17">17</numbering>
<numbering type="journalIssue">4</numbering>
</numberingGroup>
<coverDate startDate="2002-07">July/August 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="shortCommunication" position="370" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.10187</doi>
<idGroup><id type="unit" value="MDS10187"></id>
</idGroup>
<countGroup><count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup><title type="articleCategory">Clinical/Scientific Note</title>
<title type="tocHeading1">Clinical/Scientific Notes</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2002 Movement Disorders Society</copyright>
<eventGroup><event type="manuscriptReceived" date="2001-07-12"></event>
<event type="manuscriptRevised" date="2001-12-28"></event>
<event type="manuscriptAccepted" date="2002-01-11"></event>
<event type="firstOnline" date="2002-04-04"></event>
<event type="publishedOnlineFinalForm" date="2002-07-22"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2002-04-04"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">831</numbering>
<numbering type="pageLast">832</numbering>
</numberingGroup>
<correspondenceTo>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima 770‐8503, Japan</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS10187.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="1"></count>
<count type="referenceTotal" number="10"></count>
<count type="wordTotal" number="1180"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
<title type="short" xml:lang="en">DAT and Parkinson's Disease</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Masataka</givenNames>
<familyName>Nishimura</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails><email normalForm="m_nishim@clin.med.tokushima-u.ac.jp">m_nishim@clin.med.tokushima‐u.ac.jp</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ryuji</givenNames>
<familyName>Kaji</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Mitsuhiro</givenNames>
<familyName>Ohta</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Ikuko</givenNames>
<familyName>Mizuta</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Sadako</givenNames>
<familyName>Kuno</familyName>
<degrees>MD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="JP" type="organization"><unparsedAffiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="JP" type="organization"><unparsedAffiliation>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="JP" type="organization"><unparsedAffiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword>
<keyword xml:id="kwd2">dopamine transporter</keyword>
<keyword xml:id="kwd3">polymorphism</keyword>
<keyword xml:id="kwd4">case‐control study</keyword>
<keyword xml:id="kwd5">early‐onset Parkinson's disease</keyword>
</keywordGroup>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>DAT and Parkinson's Disease</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan</title>
</titleInfo>
<name type="personal"><namePart type="given">Masataka</namePart>
<namePart type="family">Nishimura</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</affiliation>
<description>Correspondence: Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima 770‐8503, Japan</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ryuji</namePart>
<namePart type="family">Kaji</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical Neuroscience, Tokushima University Hospital, Tokushima, Japan</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Mitsuhiro</namePart>
<namePart type="family">Ohta</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ikuko</namePart>
<namePart type="family">Mizuta</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Sadako</namePart>
<namePart type="family">Kuno</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical Research Center, Utano National Hospital, Ukyo‐ku, Kyoto, Japan</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="brief communication">shortCommunication</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">New York</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-07</dateIssued>
<dateCaptured encoding="w3cdtf">2001-07-12</dateCaptured>
<dateValid encoding="w3cdtf">2002-01-11</dateValid>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="tables">1</extent>
<extent unit="references">10</extent>
<extent unit="words">1180</extent>
</physicalDescription>
<abstract lang="en">We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD. © 2002 Movement Disorder Society</abstract>
<subject lang="en"><genre>Keywords</genre>
<topic>Parkinson's disease</topic>
<topic>dopamine transporter</topic>
<topic>polymorphism</topic>
<topic>case‐control study</topic>
<topic>early‐onset Parkinson's disease</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<subject><genre>article category</genre>
<topic>Clinical/Scientific Note</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>4</number>
</detail>
<extent unit="pages"><start>831</start>
<end>832</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69</identifier>
<identifier type="DOI">10.1002/mds.10187</identifier>
<identifier type="ArticleID">MDS10187</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2002 Movement Disorders Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001299 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001299 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:B4B8CC9AB3FA6FF6F56543EF779ADCCE33FA0F69 |texte= Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan }}
![]() | This area was generated with Dilib version V0.6.19. | ![]() |